BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11299690)

  • 1. Is a share buyback right for your company?
    Pettit J
    Harv Bus Rev; 2001 Apr; 79(4):141-7, 170. PubMed ID: 11299690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10 ways to create shareholder value.
    Rappaport A
    Harv Bus Rev; 2006 Sep; 84(9):66-77, 155. PubMed ID: 16967621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expensing options solves nothing.
    Sahlman WA
    Harv Bus Rev; 2002 Dec; 80(12):90-6, 134. PubMed ID: 12510541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four rules for taking your message to Wall Street.
    Hutton A
    Harv Bus Rev; 2001 May; 79(5):125-32, 166. PubMed ID: 11345909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovation killers: how financial tools destroy your capacity to do new things.
    Christensen CM; Kaufman SP; Shih WC
    Harv Bus Rev; 2008 Jan; 86(1):98-105, 137. PubMed ID: 18271321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much cash does your company need?
    Passov R
    Harv Bus Rev; 2003 Nov; 81(11):119-22, 124-6, 128, 140. PubMed ID: 14619157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Take command of your growth.
    Treacy M; Sims J
    Harv Bus Rev; 2004 Apr; 82(4):127-33, 142. PubMed ID: 15077373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sharpening the intangibles edge.
    Lev B
    Harv Bus Rev; 2004 Jun; 82(6):109-16, 138. PubMed ID: 15202292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's your real cost of capital?
    McNulty JJ; Yeh TD; Schulze WS; Lubatkin MH
    Harv Bus Rev; 2002 Oct; 80(10):114-21, 130. PubMed ID: 12389465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pension roulette: have you bet too much on equities?
    Stewart GB
    Harv Bus Rev; 2003 Jun; 81(6):104-9, 138. PubMed ID: 12800721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M&A needn't be a loser's game.
    Selden L; Colvin G
    Harv Bus Rev; 2003 Jun; 81(6):70-9, 137. PubMed ID: 12800718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New thinking on how to link executive pay with performance.
    Rappaport A
    Harv Bus Rev; 1999; 77(2):91-101, 186. PubMed ID: 10387774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored, not benchmarked. A fresh look at corporate planning.
    Campbell A
    Harv Bus Rev; 1999; 77(2):41-8, 50, 189. PubMed ID: 10387771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tread lightly through these accounting minefields.
    Sherman HD; Young SD
    Harv Bus Rev; 2001; 79(7):129-35, 146. PubMed ID: 11447613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to invest in social capital.
    Prusak L; Cohen D
    Harv Bus Rev; 2001 Jun; 79(6):86-93, 147. PubMed ID: 11408980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The competitive advantage of corporate philanthropy.
    Porter ME; Kramer MR
    Harv Bus Rev; 2002 Dec; 80(12):56-68, 133. PubMed ID: 12510538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How risky is your company?
    Simons R
    Harv Bus Rev; 1999; 77(3):85-94, 209. PubMed ID: 10387580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loyalty-based management.
    Reichheld FF
    Harv Bus Rev; 1993; 71(2):64-73. PubMed ID: 10124634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The earnings game. Everyone plays, nobody wins.
    Collingwood H
    Harv Bus Rev; 2001 Jun; 79(6):65-7, 70-4, 146. PubMed ID: 11408978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Master of the house: Why a company should take control of its building projects.
    Thurm D
    Harv Bus Rev; 2005 Oct; 83(10):120-9, 158. PubMed ID: 16250630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.